Episode 44: Death in Bodybuilding
In this episode of J3 University, Luke and I discuss the past and recent deaths in bodybuilding. We breakdown some of the suggested answers to…
Category: Bodybuilding
Episode 43: Joseph Pircher: Creating the Perfect Contest Prep
In this episode of J3 University, Luke and I are joined by coach Joseph Pircher to discuss how he has evolved his contest prep approach.…
Episode 42: Is the UK the Hottest Spot for Bodybuilding?
On this Episode Luke speaks on his trip to the United Kingdom and bodybuilding culture. We compareand contrast the UK vs US culture towards bodybuilding…
Episode 41: Fat Loss Agents for the Enhanced Competitor
In this episode of J3 University, Luke and I discuss fat loss agent deployment in enhancedcompetition. We cover each potential compound that is an option…
Episode 40: Getting Too Fat? Lets Mini-Cut!
In this episode of J3 University, Luke and I discuss the ins and outs of implementing mini cuts. Often wesee offseason get into subpar territory…
Episode 39: IFBB Pro Cory Hageman: Challenges of Bikini
In this episode of J3 University, Luke and I are joined by IFBB Pro Cory Hageman to discuss her journeythrough the bikini ranks. Cory has…
Episode 38: What is a “Gaintain” Phase?
In this episode of J3 University, Luke and I discuss the transition phases betweenmuscle accrual and fat loss phases. The “gaintain” or holding phase is…
Episode 37: Prophylactic Series: Why Insulin in Enhanced Competitors?
TimestampsInsulin Function and Basic Physiology- 00:00:57What leads to insulin sensitivity? – 00:03:28Classes of Insulin- 00:13:37When to deploy insulin- 00:21:54Will Insulin therapy cause your pancreas to…
Episode 36: Victoria Felkar: Optimizing Female Hormones and Deploying PEDs
In this episode of J3 University, Luke and I are joined by Victoria Felkar, PhD(c) todiscuss female PED use in physique competition. The conversation starts…
Episode 35: Prophylactic Series: Why Metformin in Enhanced Competitors?
In this episode of J3 University, Luke and I discuss the risk of PED usage and howMetformin might serve as a harm reduction strategy. When…